Foselutoclax (UBX1325)

foselutoclax · Unity Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Foselutoclax (UBX1325), covering 2025-08-05 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) [Phase 2]

See pricing